This week, we’re tackling two common and often confusing skin conditions: seborrheic dermatitis and psoriasis.

We’ll cover the latest updates in treatment, including a newly approved non-steroidal medication that’s changing how we approach seb derm. You’ll learn why Head & Shoulders and other classic shampoos aren’t as effective for many patients anymore, and how rotating different medicated shampoos can help you get the best results from each.

We’ll also discuss Zoryve® (roflumilast) a new foam formulation that’s proving to be a game-changer for seb derm. Finally, we’ll emphasize why steroid-sparing therapies should always be considered first when non-steroidal options are available.